Ser20
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser20  -  p53 (rat)

Site Information
PLsQEtFsCLWKLLP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 447529

In vivo Characterization
Methods used to characterize site in vivo:
phospho-antibody ( 2 , 3 ) , western blotting ( 2 , 3 )
Disease tissue studied:
brain cancer ( 2 ) , glioma ( 2 )
Relevant cell line - cell type - tissue:
C6 (glial) ( 2 ) , myocyte-heart ( 3 )

Upstream Regulation
Treatments:
acetominophen ( 2 ) , angiotensin_2 ( 3 ) , etoposide ( 2 ) , fluorouracil ( 2 )

References 

1

Gogna R, et al. (2013) p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation. EMBO Mol Med 5, 1662-83
24096875   Curated Info

2

Lee YS, et al. (2006) Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen. J Pharmacol Exp Ther 317, 202-8
16330492   Curated Info

3

Grishko V, et al. (2003) Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. Am J Physiol Heart Circ Physiol 285, H2364-72
12919932   Curated Info